Latest Breaking News On - Dominick angiolillo - Page 1 : comparemela.com

Avoid Using Prasugrel With Cangrelor During PCI, SWAP-6 Affirms

The findings support current drug labeling, which says prasugrel should be given at the end of the cangrelor infusion.

Modifying Antiplatelet Therapy: ARC Consensus Aims to Standardize Definitions

Cangrelor After Ticagrelor Pretreatment in ACS Might Be OK: SWAP-5

The study found potent platelet inhibition and no drug-drug interactions, but hard outcome studies are needed, experts say.

Managing AF Patients Undergoing PCI—Some Lingering Questions

The field has more data, but cardiologists still face challenges in deciding when to drop aspirin and what anticoagulant to use.

Observational Study Supports Continuing Oral Anticoagulation During PCI

April 06, 2021 For patients sent for an unplanned PCI, a strategy of maintaining oral anticoagulation is not associated with a higher risk of ischemic complications or bleeding when compared with a strategy of interrupting the direct oral anticoagulant (DOAC) or vitamin K antagonist (VKA) a day or two before the procedure, a new observational analysis confirms. Published in the April 12, 2021, issue of JACC: Cardiovascular Interventions, the study, drawing on the large SWEDEHEART registry, supports the current recommendations from the European Society of Cardiology (ESC) for uninterrupted oral anticoagulation (U-OAC) in patients with atrial fibrillation, venous thromboembolism, or a mechanical heart valve undergoing unplanned, nonemergent PCI, investigators say.